Asia Oceania Journal of Nuclear Medicine and Biology

Asia Oceania Journal of Nuclear Medicine and Biology

A unique coincidence: Concurrent oncocytic thyroid Carcinoma and tenosynovial giant cell tumor: A case report

Document Type : Case report

Authors
1 Nuclear Medicine Department, King Hussein Cancer Center (KHCC), Amman, Jordan
2 Radiology Department, King Hussein Cancer Center (KHCC), Amman, Jordan
Abstract
Oncocytic thyroid carcinoma (OTC) and tenosynovial giant cell tumor (TGCT) are rare neoplasms with distinct biological behavior, and their coexistence has not been previously well documented. We report a rare case of concurrent recurrent OTC and diffuse-type TGCT (TGCT-D) in a 45-year-old man who presented with a rapidly enlarging soft-tissue mass involving the left ankle and foot. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) demonstrated intensely FDG-avid lesions in the thyroid bed consistent with recurrent disease, as well as a hypermetabolic infiltrative musculoskeletal lesion in the left ankle and foot, initially suspected to represent metastatic spread. However, histopathological examination of the ankle lesion established the diagnosis of TGCT-D. This case illustrates an important diagnostic pitfall in oncology imaging: FDG-avid musculoskeletal lesions in patients with known malignancy do not necessarily represent metastases. Careful integration of clinical information, cross-sectional imaging, particularly MRI, and histopathological confirmation is essential to avoid misdiagnosis and to ensure appropriate management.
Keywords
Subjects

1.    Syed A, Vanka SA, Escudero I, Ismail R, Krayem H. Oncocytic cell carcinoma of the thyroid: a case report and an overview of the diagnosis, treatment modalities, and prognosis. Cureus. 2022; 14(10): e30298. 
2.    Sciubba DM, Petteys RJ, Kang S, Than KD, Gokaslan ZL, Gallia GL, et al. Solitary spinal metastasis of Hürthle cell thyroid carcinoma. Journal of Clinical Neuroscience. 2010; 17(6): 797-801.
3.    Rahbari R, Zhang L, Kebebew E. Thyroid cancer gender disparity. Future oncology. 2010; 6(11): 1771-9.
4.    Zhang K, Wang X, Wei T, Li Z, Zhu J, Chen YW. Radioactive iodine therapy improves overall survival outcome in oncocytic carcinoma of the thyroid by reducing death risks from noncancer causes: A competing risk analysis of 4641 patients. Head & Neck. 2024; 46(10): 2550-68.
5.    Stacchiotti S, Dürr HR, Schaefer IM, Woertler K, Haas R, Trama A, et al. Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts. Cancer treatment reviews. 2023; 112: 102491.
6.    Kager M, Kager R, Fałek P, Fałek A, Szczypiór G, Niemunis-Sawicka J, et al. Tenosynovial giant cell tumor. Folia Medica Cracoviensia. 2022; 62(2): 93-107.
7.    Ehrenstein V, Andersen SL, Qazi I, Sankar N, Pedersen AB, Sikorski R, et al. Tenosynovial Giant Cell Tumor: Incidence, Prevalence, Patient Characteristics, and Recurrence. A Registry-based Cohort Study in Denmark. The Journal of Rheumatology. 2017; 44(10): 1476-83.
8.    Palmerini E, Staals EL. Treatment updates on tenosynovial giant cell tumor. Current Opinion in Oncology. 2022; 34(4): 322-7.
9.    Chang KJ, Byun BH, Moon HS, Park J, Koh JS, Kim BI, et al. Tenosynovial Giant Cell Tumor of Diffuse Type Mimicking Bony Metastasis Detected on F-18 FDG PET/CT. Nuclear Medicine and Molecular Imaging. 2014; 48(3): 230-2.
10.Siegel M, Bode L, Südkamp N, Kühle J, Zwingmann J, Schmal H, et al. Treatment, recurrence rates and follow-up of Tenosynovial Giant Cell Tumor (TGCT) of the foot and ankle-A systematic review and meta-analysis. PLOS ONE. 2021; 16(12): e0260795.
11.Choi WS, Lee SK, Kim JY, Kim Y. Diffuse-Type Tenosynovial Giant Cell Tumor: What Are the Important Findings on the Initial and Follow-Up MRI? Cancers (Basel). 2024; 16(2).
12.Chen EL, de Castro CM, Hendzel KD, Iwaz S, Kim MA, Valeshabad AK, et al. Histologically benign metastasizing tenosynovial giant cell tumor mimicking metastatic malignancy: A case report and review of literature. Radiology Case Reports. 2019; 14(8): 934-40.
13.Takeuchi A, Yamamoto N, Hayashi K, Miwa S, Takahira M, Fukui K, et al. Tenosynovial giant cell tumors in unusual locations detected by positron emission tomography imaging confused with malignant tumors: report of two cases. BMC Musculoskeletal Disorders. 2016; 17(1): 180.
14.Al-Ibraheem A, Moghrabi S, Abdlkadir AS, Haidar M, Jaber O. Unmasking Coincident Hodgkin Lymphoma and Giant Cell Tumor: Insights from [(18)F] FDG PET/CT. Asia Oceania Journal of Nuclear Medicine and Biology. 2024; 12(1): 57-60.
15.Cañete Sánchez FM, Romero Robles LG, Boulvard Chollet XL, Mangas Losada M, Garrastachu P, Cabrera Villegas A, et al. Unusual Uptake of [(131)I] in a Tenosynovial Giant Cell Tumour Relapse in a Patient with Differentiated Thyroid Cancer.  Molecular Imaging and Radionuclide Therapy. 2022; 31(2): 145-7.
16.Mizuta K, Oshiro H, Tsuha Y, Tome Y, Nishida K. Imaging characteristics of tenosynovial giant cell tumors on 18F-fluorodeoxyglucose positron emission tomography/computed tomography: a retrospective observational study. BMC Musculoskeletal Disorders. 2023; 24(1): 593.
17.Wu C-C, Chou Y-H, Yang W-J, Hsu J-D, Tseng H-C, Lee Y-C. Recurrent diffuse-type tenosynovial giant cell tumor of the left ankle: a case report. Therapeutic Radiology and Oncology. 2019; 3:17.
18.Loharkar S, Basu S. Tenosynovial Giant Cell Tumor of Foot in a Patient with Radioiodine-Refractory Thyroid Cancer: Imaging Findings on FDG-PET/CT, MRI, and Radioiodine Scan. World Journal of Nuclear Medicine. 2023; 22(1): 63-6.
19.Pina S, Fernandez M, Maya S, Garcia RA, Noor A, Pawha PS, et al. Recurrent Temporal Bone Tenosynovial Giant Cell Tumor with Chondroid Metaplasia: The Use of Imaging to Assess Recurrence. The Neuroradiology Journal. 2014; 27(1): 97-101.